REBECCA SMITH: Open Payments
NPI 1417249988 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 14 payments from 9 companies in 2025. Trend: 2023 $200 · 2024 $300 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $97 |
| SPR Therapeutics, Inc | 2 | $46 |
| Medtronic, Inc. | 1 | $33 |
| Boston Scientific Corporation | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Curonix LLC | 1 | $14 |
Products named: QULIPTA, SPRINT PNS System, INTELLIS ADAPTIVESTIM, WaveWriter Alpha Prime 16, RELISTOR, SHINGRIX, JOURNAVX, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
